TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Veterinary Biological Vaccines Market Research Report 2022

Global Veterinary Biological Vaccines Market Research Report 2022

  • Category:Life Sciences
  • Published on : 24 October 2022
  • Pages :120
  • Formats:
  • Report Code:SMR-7459284
OfferClick for best price

Best Price: $2320

Veterinary Biological Vaccines Market Size, Share 2022


Market Analysis and Insights: Global Veterinary Biological Vaccines Market

The global Veterinary Biological Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Veterinary Biological Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Veterinary Biological Vaccines market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Veterinary Biological Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Veterinary Biological Vaccines market.

Global Veterinary Biological Vaccines Scope and Market Size

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Live Attenuated Vaccines

Inactivated Vaccines

Others

Segment by Application

Livestock

Swine

Chicken

Others

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

By Company

Merck

Zoetis

Boehringer Ingelheim

Ceva

CAHIC

HVRI

Yebio

DHN

WINSUN

Elanco

Virbac

CAVAC

Kyoto Biken Laboratories

FATRO

Vaksindo

Bio-Labs

Avimex Animal Health

MEVAC

Biovac

Atafen

Dyntec

Ringpu Biology

Jinyu Bio-technology

Jinhe Biotechnology

China Animal Husbandry Industry

Wuhan Keqian Biology

Pulike Biological Engineering

Chengdu Kanghua Biological Products

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Veterinary Biological Vaccines product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Veterinary Biological Vaccines, with price, sales, revenue, and global market share of Veterinary Biological Vaccines from 2019 to 2022.

Chapter 3, the Veterinary Biological Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Veterinary Biological Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Veterinary Biological Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Veterinary Biological Vaccines.

Chapter 13, 14, and 15, to describe Veterinary Biological Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Veterinary Biological Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Veterinary Biological Vaccines Market Research Report 2022
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 120 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Veterinary Biological Vaccines Market Overview
1.1 Product Overview and Scope of Veterinary Biological Vaccines
1.2 Veterinary Biological Vaccines Segment by Type
1.2.1 Global Veterinary Biological Vaccines Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Others
1.3 Veterinary Biological Vaccines Segment by Application
1.3.1 Global Veterinary Biological Vaccines Sales Comparison by Application: (2022-2028)
1.3.2 Livestock
1.3.3 Swine
1.3.4 Chicken
1.3.5 Others
1.4 Global Veterinary Biological Vaccines Market Size Estimates and Forecasts
1.4.1 Global Veterinary Biological Vaccines Revenue 2017-2028
1.4.2 Global Veterinary Biological Vaccines Sales 2017-2028
1.4.3 Veterinary Biological Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028
2 Veterinary Biological Vaccines Market Competition by Manufacturers
2.1 Global Veterinary Biological Vaccines Sales Market Share by Manufacturers (2017-2022)
2.2 Global Veterinary Biological Vaccines Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Veterinary Biological Vaccines Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Veterinary Biological Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Veterinary Biological Vaccines Market Competitive Situation and Trends
2.5.1 Veterinary Biological Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Veterinary Biological Vaccines Players Market Share by Revenue
2.5.3 Global Veterinary Biological Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Biological Vaccines Retrospective Market Scenario by Region
3.1 Global Veterinary Biological Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Veterinary Biological Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Veterinary Biological Vaccines Market Facts & Figures by Country
3.3.1 North America Veterinary Biological Vaccines Sales by Country
3.3.2 North America Veterinary Biological Vaccines Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Veterinary Biological Vaccines Market Facts & Figures by Country
3.4.1 Europe Veterinary Biological Vaccines Sales by Country
3.4.2 Europe Veterinary Biological Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Veterinary Biological Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Veterinary Biological Vaccines Sales by Region
3.5.2 Asia Pacific Veterinary Biological Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Veterinary Biological Vaccines Market Facts & Figures by Country
3.6.1 Latin America Veterinary Biological Vaccines Sales by Country
3.6.2 Latin America Veterinary Biological Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Veterinary Biological Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Veterinary Biological Vaccines Sales by Country
3.7.2 Middle East and Africa Veterinary Biological Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Veterinary Biological Vaccines Historic Market Analysis by Type
4.1 Global Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)
4.2 Global Veterinary Biological Vaccines Revenue Market Share by Type (2017-2022)
4.3 Global Veterinary Biological Vaccines Price by Type (2017-2022)
5 Global Veterinary Biological Vaccines Historic Market Analysis by Application
5.1 Global Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)
5.2 Global Veterinary Biological Vaccines Revenue Market Share by Application (2017-2022)
5.3 Global Veterinary Biological Vaccines Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck Veterinary Biological Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Zoetis Veterinary Biological Vaccines Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Boehringer Ingelheim Veterinary Biological Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Ceva Veterinary Biological Vaccines Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 CAHIC
6.5.1 CAHIC Corporation Information
6.5.2 CAHIC Description and Business Overview
6.5.3 CAHIC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.5.4 CAHIC Veterinary Biological Vaccines Product Portfolio
6.5.5 CAHIC Recent Developments/Updates
6.6 HVRI
6.6.1 HVRI Corporation Information
6.6.2 HVRI Description and Business Overview
6.6.3 HVRI Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.6.4 HVRI Veterinary Biological Vaccines Product Portfolio
6.6.5 HVRI Recent Developments/Updates
6.7 Yebio
6.6.1 Yebio Corporation Information
6.6.2 Yebio Description and Business Overview
6.6.3 Yebio Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Yebio Veterinary Biological Vaccines Product Portfolio
6.7.5 Yebio Recent Developments/Updates
6.8 DHN
6.8.1 DHN Corporation Information
6.8.2 DHN Description and Business Overview
6.8.3 DHN Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.8.4 DHN Veterinary Biological Vaccines Product Portfolio
6.8.5 DHN Recent Developments/Updates
6.9 WINSUN
6.9.1 WINSUN Corporation Information
6.9.2 WINSUN Description and Business Overview
6.9.3 WINSUN Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.9.4 WINSUN Veterinary Biological Vaccines Product Portfolio
6.9.5 WINSUN Recent Developments/Updates
6.10 Elanco
6.10.1 Elanco Corporation Information
6.10.2 Elanco Description and Business Overview
6.10.3 Elanco Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Elanco Veterinary Biological Vaccines Product Portfolio
6.10.5 Elanco Recent Developments/Updates
6.11 Virbac
6.11.1 Virbac Corporation Information
6.11.2 Virbac Veterinary Biological Vaccines Description and Business Overview
6.11.3 Virbac Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Virbac Veterinary Biological Vaccines Product Portfolio
6.11.5 Virbac Recent Developments/Updates
6.12 CAVAC
6.12.1 CAVAC Corporation Information
6.12.2 CAVAC Veterinary Biological Vaccines Description and Business Overview
6.12.3 CAVAC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.12.4 CAVAC Veterinary Biological Vaccines Product Portfolio
6.12.5 CAVAC Recent Developments/Updates
6.13 Kyoto Biken Laboratories
6.13.1 Kyoto Biken Laboratories Corporation Information
6.13.2 Kyoto Biken Laboratories Veterinary Biological Vaccines Description and Business Overview
6.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Portfolio
6.13.5 Kyoto Biken Laboratories Recent Developments/Updates
6.14 FATRO
6.14.1 FATRO Corporation Information
6.14.2 FATRO Veterinary Biological Vaccines Description and Business Overview
6.14.3 FATRO Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.14.4 FATRO Veterinary Biological Vaccines Product Portfolio
6.14.5 FATRO Recent Developments/Updates
6.15 Vaksindo
6.15.1 Vaksindo Corporation Information
6.15.2 Vaksindo Veterinary Biological Vaccines Description and Business Overview
6.15.3 Vaksindo Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Vaksindo Veterinary Biological Vaccines Product Portfolio
6.15.5 Vaksindo Recent Developments/Updates
6.16 Bio-Labs
6.16.1 Bio-Labs Corporation Information
6.16.2 Bio-Labs Veterinary Biological Vaccines Description and Business Overview
6.16.3 Bio-Labs Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Bio-Labs Veterinary Biological Vaccines Product Portfolio
6.16.5 Bio-Labs Recent Developments/Updates
6.17 Avimex Animal Health
6.17.1 Avimex Animal Health Corporation Information
6.17.2 Avimex Animal Health Veterinary Biological Vaccines Description and Business Overview
6.17.3 Avimex Animal Health Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Avimex Animal Health Veterinary Biological Vaccines Product Portfolio
6.17.5 Avimex Animal Health Recent Developments/Updates
6.18 MEVAC
6.18.1 MEVAC Corporation Information
6.18.2 MEVAC Veterinary Biological Vaccines Description and Business Overview
6.18.3 MEVAC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.18.4 MEVAC Veterinary Biological Vaccines Product Portfolio
6.18.5 MEVAC Recent Developments/Updates
6.19 Biovac
6.19.1 Biovac Corporation Information
6.19.2 Biovac Veterinary Biological Vaccines Description and Business Overview
6.19.3 Biovac Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Biovac Veterinary Biological Vaccines Product Portfolio
6.19.5 Biovac Recent Developments/Updates
6.20 Atafen
6.20.1 Atafen Corporation Information
6.20.2 Atafen Veterinary Biological Vaccines Description and Business Overview
6.20.3 Atafen Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Atafen Veterinary Biological Vaccines Product Portfolio
6.20.5 Atafen Recent Developments/Updates
6.21 Dyntec
6.21.1 Dyntec Corporation Information
6.21.2 Dyntec Veterinary Biological Vaccines Description and Business Overview
6.21.3 Dyntec Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Dyntec Veterinary Biological Vaccines Product Portfolio
6.21.5 Dyntec Recent Developments/Updates
6.22 Ringpu Biology
6.22.1 Ringpu Biology Corporation Information
6.22.2 Ringpu Biology Veterinary Biological Vaccines Description and Business Overview
6.22.3 Ringpu Biology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Ringpu Biology Veterinary Biological Vaccines Product Portfolio
6.22.5 Ringpu Biology Recent Developments/Updates
6.23 Jinyu Bio-technology
6.23.1 Jinyu Bio-technology Corporation Information
6.23.2 Jinyu Bio-technology Veterinary Biological Vaccines Description and Business Overview
6.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Jinyu Bio-technology Veterinary Biological Vaccines Product Portfolio
6.23.5 Jinyu Bio-technology Recent Developments/Updates
6.24 Jinhe Biotechnology
6.24.1 Jinhe Biotechnology Corporation Information
6.24.2 Jinhe Biotechnology Veterinary Biological Vaccines Description and Business Overview
6.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Jinhe Biotechnology Veterinary Biological Vaccines Product Portfolio
6.24.5 Jinhe Biotechnology Recent Developments/Updates
6.25 China Animal Husbandry Industry
6.25.1 China Animal Husbandry Industry Corporation Information
6.25.2 China Animal Husbandry Industry Veterinary Biological Vaccines Description and Business Overview
6.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.25.4 China Animal Husbandry Industry Veterinary Biological Vaccines Product Portfolio
6.25.5 China Animal Husbandry Industry Recent Developments/Updates
6.26 Wuhan Keqian Biology
6.26.1 Wuhan Keqian Biology Corporation Information
6.26.2 Wuhan Keqian Biology Veterinary Biological Vaccines Description and Business Overview
6.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.26.4 Wuhan Keqian Biology Veterinary Biological Vaccines Product Portfolio
6.26.5 Wuhan Keqian Biology Recent Developments/Updates
6.27 Pulike Biological Engineering
6.27.1 Pulike Biological Engineering Corporation Information
6.27.2 Pulike Biological Engineering Veterinary Biological Vaccines Description and Business Overview
6.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.27.4 Pulike Biological Engineering Veterinary Biological Vaccines Product Portfolio
6.27.5 Pulike Biological Engineering Recent Developments/Updates
6.28 Chengdu Kanghua Biological Products
6.28.1 Chengdu Kanghua Biological Products Corporation Information
6.28.2 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Description and Business Overview
6.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.28.4 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Portfolio
6.28.5 Chengdu Kanghua Biological Products Recent Developments/Updates
7 Veterinary Biological Vaccines Manufacturing Cost Analysis
7.1 Veterinary Biological Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Veterinary Biological Vaccines
7.4 Veterinary Biological Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Veterinary Biological Vaccines Distributors List
8.3 Veterinary Biological Vaccines Customers
9 Veterinary Biological Vaccines Market Dynamics
9.1 Veterinary Biological Vaccines Industry Trends
9.2 Veterinary Biological Vaccines Market Drivers
9.3 Veterinary Biological Vaccines Market Challenges
9.4 Veterinary Biological Vaccines Market Restraints
10 Global Market Forecast
10.1 Veterinary Biological Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Veterinary Biological Vaccines by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Veterinary Biological Vaccines by Type (2023-2028)
10.2 Veterinary Biological Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Veterinary Biological Vaccines by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Veterinary Biological Vaccines by Application (2023-2028)
10.3 Veterinary Biological Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Veterinary Biological Vaccines by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Veterinary Biological Vaccines by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Veterinary Biological Vaccines Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Veterinary Biological Vaccines Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Veterinary Biological Vaccines Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Veterinary Biological Vaccines Market Competitive Situation by Manufacturers in 2021
Table 5. Global Veterinary Biological Vaccines Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Veterinary Biological Vaccines Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Veterinary Biological Vaccines Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Veterinary Biological Vaccines Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Veterinary Biological Vaccines Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Veterinary Biological Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Veterinary Biological Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Veterinary Biological Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Biological Vaccines as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Veterinary Biological Vaccines Sales by Region (2017-2022) & (K Units)
Table 16. Global Veterinary Biological Vaccines Sales Market Share by Region (2017-2022)
Table 17. Global Veterinary Biological Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Veterinary Biological Vaccines Revenue Market Share by Region (2017-2022)
Table 19. North America Veterinary Biological Vaccines Sales by Country (2017-2022) & (K Units)
Table 20. North America Veterinary Biological Vaccines Sales Market Share by Country (2017-2022)
Table 21. North America Veterinary Biological Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Veterinary Biological Vaccines Revenue Market Share by Country (2017-2022)
Table 23. Europe Veterinary Biological Vaccines Sales by Country (2017-2022) & (K Units)
Table 24. Europe Veterinary Biological Vaccines Sales Market Share by Country (2017-2022)
Table 25. Europe Veterinary Biological Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Veterinary Biological Vaccines Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Veterinary Biological Vaccines Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Veterinary Biological Vaccines Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Veterinary Biological Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Veterinary Biological Vaccines Revenue Market Share by Region (2017-2022)
Table 31. Latin America Veterinary Biological Vaccines Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Veterinary Biological Vaccines Sales Market Share by Country (2017-2022)
Table 33. Latin America Veterinary Biological Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Veterinary Biological Vaccines Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Veterinary Biological Vaccines Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Veterinary Biological Vaccines Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Veterinary Biological Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Veterinary Biological Vaccines Revenue Market Share by Country (2017-2022)
Table 39. Global Veterinary Biological Vaccines Sales by Type (2017-2022) & (K Units)
Table 40. Global Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)
Table 41. Global Veterinary Biological Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Veterinary Biological Vaccines Revenue Share by Type (2017-2022)
Table 43. Global Veterinary Biological Vaccines Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Veterinary Biological Vaccines Sales (K Units) by Application (2017-2022)
Table 45. Global Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)
Table 46. Global Veterinary Biological Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Veterinary Biological Vaccines Revenue Share by Application (2017-2022)
Table 48. Global Veterinary Biological Vaccines Price by Application (2017-2022) & (US$/Unit)
Table 49. Merck Corporation Information
Table 50. Merck Description and Business Overview
Table 51. Merck Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Merck Veterinary Biological Vaccines Product
Table 53. Merck Recent Developments/Updates
Table 54. Zoetis Corporation Information
Table 55. Zoetis Description and Business Overview
Table 56. Zoetis Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Zoetis Veterinary Biological Vaccines Product
Table 58. Zoetis Recent Developments/Updates
Table 59. Boehringer Ingelheim Corporation Information
Table 60. Boehringer Ingelheim Description and Business Overview
Table 61. Boehringer Ingelheim Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Boehringer Ingelheim Veterinary Biological Vaccines Product
Table 63. Boehringer Ingelheim Recent Developments/Updates
Table 64. Ceva Corporation Information
Table 65. Ceva Description and Business Overview
Table 66. Ceva Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Ceva Veterinary Biological Vaccines Product
Table 68. Ceva Recent Developments/Updates
Table 69. CAHIC Corporation Information
Table 70. CAHIC Description and Business Overview
Table 71. CAHIC Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. CAHIC Veterinary Biological Vaccines Product
Table 73. CAHIC Recent Developments/Updates
Table 74. HVRI Corporation Information
Table 75. HVRI Description and Business Overview
Table 76. HVRI Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. HVRI Veterinary Biological Vaccines Product
Table 78. HVRI Recent Developments/Updates
Table 79. Yebio Corporation Information
Table 80. Yebio Description and Business Overview
Table 81. Yebio Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Yebio Veterinary Biological Vaccines Product
Table 83. Yebio Recent Developments/Updates
Table 84. DHN Corporation Information
Table 85. DHN Description and Business Overview
Table 86. DHN Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. DHN Veterinary Biological Vaccines Product
Table 88. DHN Recent Developments/Updates
Table 89. WINSUN Corporation Information
Table 90. WINSUN Description and Business Overview
Table 91. WINSUN Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. WINSUN Veterinary Biological Vaccines Product
Table 93. WINSUN Recent Developments/Updates
Table 94. Elanco Corporation Information
Table 95. Elanco Description and Business Overview
Table 96. Elanco Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Elanco Veterinary Biological Vaccines Product
Table 98. Elanco Recent Developments/Updates
Table 99. Virbac Corporation Information
Table 100. Virbac Description and Business Overview
Table 101. Virbac Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Virbac Veterinary Biological Vaccines Product
Table 103. Virbac Recent Developments/Updates
Table 104. CAVAC Corporation Information
Table 105. CAVAC Description and Business Overview
Table 106. CAVAC Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. CAVAC Veterinary Biological Vaccines Product
Table 108. CAVAC Recent Developments/Updates
Table 109. Kyoto Biken Laboratories Corporation Information
Table 110. Kyoto Biken Laboratories Description and Business Overview
Table 111. Kyoto Biken Laboratories Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Kyoto Biken Laboratories Veterinary Biological Vaccines Product
Table 113. Kyoto Biken Laboratories Recent Developments/Updates
Table 114. FATRO Corporation Information
Table 115. FATRO Description and Business Overview
Table 116. FATRO Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. FATRO Veterinary Biological Vaccines Product
Table 118. FATRO Recent Developments/Updates
Table 119. Vaksindo Corporation Information
Table 120. Vaksindo Description and Business Overview
Table 121. Vaksindo Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Vaksindo Veterinary Biological Vaccines Product
Table 123. Vaksindo Recent Developments/Updates
Table 124. Bio-Labs Corporation Information
Table 125. Bio-Labs Description and Business Overview
Table 126. Bio-Labs Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Bio-Labs Veterinary Biological Vaccines Product
Table 128. Bio-Labs Recent Developments/Updates
Table 129. Avimex Animal Health Corporation Information
Table 130. Avimex Animal Health Description and Business Overview
Table 131. Avimex Animal Health Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Avimex Animal Health Veterinary Biological Vaccines Product
Table 133. Avimex Animal Health Recent Developments/Updates
Table 134. MEVAC Corporation Information
Table 135. MEVAC Description and Business Overview
Table 136. MEVAC Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. MEVAC Veterinary Biological Vaccines Product
Table 138. MEVAC Recent Developments/Updates
Table 139. Biovac Corporation Information
Table 140. Biovac Description and Business Overview
Table 141. Biovac Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Biovac Veterinary Biological Vaccines Product
Table 143. Biovac Recent Developments/Updates
Table 144. Atafen Corporation Information
Table 145. Atafen Description and Business Overview
Table 146. Atafen Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Atafen Veterinary Biological Vaccines Product
Table 148. Atafen Recent Developments/Updates
Table 149. Dyntec Corporation Information
Table 150. Dyntec Description and Business Overview
Table 151. Dyntec Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Dyntec Veterinary Biological Vaccines Product
Table 153. Dyntec Recent Developments/Updates
Table 154. Ringpu Biology Corporation Information
Table 155. Ringpu Biology Description and Business Overview
Table 156. Ringpu Biology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 157. Ringpu Biology Veterinary Biological Vaccines Product
Table 158. Ringpu Biology Recent Developments/Updates
Table 159. Jinyu Bio-technology Corporation Information
Table 160. Jinyu Bio-technology Description and Business Overview
Table 161. Jinyu Bio-technology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 162. Jinyu Bio-technology Veterinary Biological Vaccines Product
Table 163. Jinyu Bio-technology Recent Developments/Updates
Table 164. Jinhe Biotechnology Corporation Information
Table 165. Jinhe Biotechnology Description and Business Overview
Table 166. Jinhe Biotechnology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 167. Jinhe Biotechnology Veterinary Biological Vaccines Product
Table 168. Jinhe Biotechnology Recent Developments/Updates
Table 169. China Animal Husbandry Industry Corporation Information
Table 170. China Animal Husbandry Industry Description and Business Overview
Table 171. China Animal Husbandry Industry Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 172. China Animal Husbandry Industry Veterinary Biological Vaccines Product
Table 173. China Animal Husbandry Industry Recent Developments/Updates
Table 174. Wuhan Keqian Biology Corporation Information
Table 175. Wuhan Keqian Biology Description and Business Overview
Table 176. Wuhan Keqian Biology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 177. Wuhan Keqian Biology Veterinary Biological Vaccines Product
Table 178. Wuhan Keqian Biology Recent Developments/Updates
Table 179. Pulike Biological Engineering Corporation Information
Table 180. Pulike Biological Engineering Description and Business Overview
Table 181. Pulike Biological Engineering Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 182. Pulike Biological Engineering Veterinary Biological Vaccines Product
Table 183. Pulike Biological Engineering Recent Developments/Updates
Table 184. Chengdu Kanghua Biological Products Corporation Information
Table 185. Chengdu Kanghua Biological Products Description and Business Overview
Table 186. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 187. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product
Table 188. Chengdu Kanghua Biological Products Recent Developments/Updates
Table 189. Production Base and Market Concentration Rate of Raw Material
Table 190. Key Suppliers of Raw Materials
Table 191. Veterinary Biological Vaccines Distributors List
Table 192. Veterinary Biological Vaccines Customers List
Table 193. Veterinary Biological Vaccines Market Trends
Table 194. Veterinary Biological Vaccines Market Drivers
Table 195. Veterinary Biological Vaccines Market Challenges
Table 196. Veterinary Biological Vaccines Market Restraints
Table 197. Global Veterinary Biological Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 198. Global Veterinary Biological Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 199. Global Veterinary Biological Vaccines Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 200. Global Veterinary Biological Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 201. Global Veterinary Biological Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 202. Global Veterinary Biological Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 203. Global Veterinary Biological Vaccines Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 204. Global Veterinary Biological Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 205. Global Veterinary Biological Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 206. Global Veterinary Biological Vaccines Sales Market Share Forecast by Region (2023-2028)
Table 207. Global Veterinary Biological Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 208. Global Veterinary Biological Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 209. Research Programs/Design for This Report
Table 210. Key Data Information from Secondary Sources
Table 211. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Veterinary Biological Vaccines
Figure 2. Global Veterinary Biological Vaccines Market Share by Type in 2021 & 2028
Figure 3. Live Attenuated Vaccines Product Picture
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Others Product Picture
Figure 6. Global Veterinary Biological Vaccines Market Share by Application in 2021 & 2028
Figure 7. Livestock
Figure 8. Swine
Figure 9. Chicken
Figure 10. Others
Figure 11. Global Veterinary Biological Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Veterinary Biological Vaccines Market Size (2017-2028) & (US$ Million)
Figure 13. Global Veterinary Biological Vaccines Sales (2017-2028) & (K Units)
Figure 14. Veterinary Biological Vaccines Sales Share by Manufacturers in 2021
Figure 15. Global Veterinary Biological Vaccines Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Veterinary Biological Vaccines Players: Market Share by Revenue in 2021
Figure 17. Veterinary Biological Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Veterinary Biological Vaccines Sales Market Share by Region (2017-2022)
Figure 19. Global Veterinary Biological Vaccines Sales Market Share by Region in 2021
Figure 20. Global Veterinary Biological Vaccines Revenue Market Share by Region (2017-2022)
Figure 21. Global Veterinary Biological Vaccines Revenue Market Share by Region in 2021
Figure 22. United States Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Colombia Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Veterinary Biological Vaccines by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Veterinary Biological Vaccines
Figure 47. Manufacturing Process Analysis of Veterinary Biological Vaccines
Figure 48. Veterinary Biological Vaccines Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount